Microbot Medical Trademarks “One & Done®”

Microbot Medical (Nasdaq: MBOT) has been granted a registered trademark from the US Patent and Trademark Office for a feature of the company’s LIBERTY Robotic Surgical System which is being developed to integrate guidewires, microcatheters and other instruments required for complete endovascular procedures using the device.

LIBERTY is the first ever single-use endovascular surgical robotic system designed to streamline endovascular procedures.

Highlights

With this trademark, the Company continues to expand its proprietary assets, including numerous approved and pending patents all over the world, and differentiate its product’s capabilities.

Microbot Medical is the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system. 

About Microbot Medical 

Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, with the goals of improving clinical outcomes for patients and increasing accessibility through the natural and artificial lumens within the human body.

The LIBERTY Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures today, by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The Company believes the LIBERTY Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.
Further information about Microbot Medical is available at http://www.microbotmedical.com.